Table 1.
Characteristics of patients (n=26) with thrombosis identified on FDG-PET/CT
| Age (years) | |
| Mean | 61.9 |
| Range | 24-82 |
| Gender | |
| Female | 11 (42.3%) |
| Male | 15 (57.7%) |
| Race | |
| White | 16 (61.6%) |
| Black | 5 (19.2%) |
| Asian | 2 (7.7%) |
| Hispanic | 1 (3.8%) |
| Unknown | 2 (7.7%) |
| Patients status | |
| Deceased | 19 (73.1%) |
| Alive | 7 (26.9%) |
| BMI (kg/m2) | |
| Mean | 25.4 |
| Range | 18.6-43.5 |
| BMI between 18.5-24.5 | 15 (57.7%) |
| BMI between 25-29.9 | 5 (19.2%) |
| BMI between 30-39.9 | 4 (15.4%) |
| BMI more than 40 | 1 (3.8%) |
| Unknown | 1 (3.8%) |
| History of thromboembolic events | |
| DVT | 18 (69.2%) |
| PE | 13 (50.0%) |
| Thrombosis site | |
| IVC | 14 (53.8%) |
| SVC | 1 (3.8%) |
| Lower extremity vein | 9 (34.6%) |
| Jugular vein | 2 (7.7%) |
| Confirmation with other imaging modality | |
| Yes | 6 (23.1%) |
| No | 20 (76.9%) |
| Underlying malignancy | |
| Lung cancer | 7 (26.9%) |
| Lymphoma | 6 (23.1%) |
| Gastrointestinal cancers | 3 (11.6%) |
| Gynecological cancer | 3 (11.6%) |
| Breast cancer | 1 (3.8%) |
| Bladder cancer | 1 (3.8%) |
| Melanoma | 1 (3.8%) |
| Thymoma | 1 (3.8%) |
| Head and neck | 1 (3.8%) |
| Unknown | 2 (7.7%) |
| Histological subtype of the cancer | |
| Adenocarcinoma | 9 (34.6%) |
| SCC | 3 (11.5%) |
| Diffuse large B-cell lymphoma | 3 (11.5%) |
| Hodgkin’s disease | 2 (7.7%) |
| Non-small cell lung cancer | 2 (7.7%) |
| Unknown primary | 1 (3.8%) |
| Others | 6 (23.1%) |
| Stage of the malignancy | |
| Stage 1 | 1 (3.8%) |
| Stage 2 | 1 (3.8%) |
| Stage 3 | 6 (23.1%) |
| Stage 4 | 14 (53.8%) |
| Unknown | 4 (15.4%) |
| Treatment of underlying malignancy | |
| Chemotherapy | 12 (46.2%) |
| Radiotherapy | 7 (26.9%) |
| Surgery | 9 (34.6%) |
| Presence of metastasis | |
| At the time of diagnosis | 21 (80.8%) |
| At the time of PET/CT scan | 23 (88.5%) |
| Underlying condition | |
| Pulmonary disease | 5 (19.2%) |
| Renal disease | 9 (34.6%) |
| History of infection prior PET/CT | 11 (42.3%) |
| Presence of indwelling catheter | 17 (65.4%) |
| Anemia | 20 (76.9%) |
| Leukocytosis | 1 (3.8%) |
| Leukopenia | 2 (7.7%) |
| Thrombocytosis | 4 (15.4%) |
| Thrombocytopenia | 2 (7.7%) |
| Complete blood count (mean, mg/dl) | |
| WBC | 8.2 |
| Hgb | 10.9 |
| Platelet | 313.6 |
BMI = body mass index, DVT = deep vein thrombosis, PE = pulmonary embolism, IVC = inferior vena cava, SVC = superior vena cava, SCC = squamous cell carcinoma, WBC = white blood cells, Hgb = hemoglobin.